CDC42 与炎症性肠病和高血糖相关的调控模式
Marija Stojanovic1,2, Devendra K Agrawal1
1Department of Translational Research, Western University of Health Sciences, Pomona, California 91766, USA.
概括
细胞功能的关键调节者Cdc42与炎症性肠病 (IBD) 和高血糖症有关. 生物信息学分析预测了基因相互作用,表明了在糖尿病患者中治疗IBD的潜在治疗点.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物信息学是一种生物信息学.
背景情况:
- Cdc42是一种调节细胞骨动力学和细胞极性等基本细胞过程的Rho GTPase.
- Cdc42在胃肠上皮质屏障功能和胰岛素分泌中发挥作用.
- 有证据表明,Cdc42在炎症性肠病 (IBD) 和高血糖症 (糖尿病) 中发出信号.
研究的目的:
- 研究Cdc42信号在高血糖条件下的炎症性肠病病理生理学中的作用.
- 使用生物信息学分析预测与IBD和高血糖症中Cdc42信号相关的转录因子-基因相互作用.
主要方法:
- 生物信息学分析被用来预测转录因子-基因相互作用.
- 在分析中,确定了影响Cdc42相关基因表达的关键分子.
主要成果:
- 该研究预测了基因和参与Cdc42信号传递的转录因子之间的各种相互作用.
- 在分析中发现了在IBD和高血糖症的背景下对特定基因具有显著预测效应的分子.
结论:
- 了解Cdc42在IBD和高血糖症中的分子途径至关重要.
- 预测的相互作用突出了疾病管理和控制的潜在治疗目标.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
134
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
134
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
259
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
259
Inflammatory Bowel Disease I: Ulcerative Colitis
99
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
99
Chronic Bowel Disorders: Introduction
345
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
345
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K


